We serve Chemical Name:1-(3-Fluorobenzyl)-4-methyl-1H-pyrazol-5-amine CAS:1015845-64-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(3-Fluorobenzyl)-4-methyl-1H-pyrazol-5-amine
CAS.NO:1015845-64-3
Synonyms:2-[(3-fluorophenyl)methyl]-4-methylpyrazol-3-amine
Molecular Formula:C11H12FN3
Molecular Weight:205.23100
HS Code:2933199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.84000
Exact Mass:205.10200
LogP:2.54230
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-[(3-fluorophenyl)methyl]-4-methylpyrazol-3-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(3-fluorophenyl)methyl]-4-methylpyrazol-3-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(3-fluorophenyl)methyl]-4-methylpyrazol-3-amine Use and application,2-[(3-fluorophenyl)methyl]-4-methylpyrazol-3-amine technical grade,usp/ep/jp grade.
Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 1-(3-Fluorobenzyl)-4-methyl-1H-pyrazol-5-amine manufacturer Health officials said it remained unclear where he had developed the disease. 1-(3-Fluorobenzyl)-4-methyl-1H-pyrazol-5-amine supplier Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more. 1-(3-Fluorobenzyl)-4-methyl-1H-pyrazol-5-amine vendor Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. 1-(3-Fluorobenzyl)-4-methyl-1H-pyrazol-5-amine factory Health officials said it remained unclear where he had developed the disease.
